Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.

Slides:



Advertisements
Similar presentations
The Role of the IRB An Institutional Review Board (IRB) is a review committee established to help protect the rights and welfare of human research subjects.
Advertisements

Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB
Gerald Treiman, IRB Chair John Stillman, IRB Director Maureen Brinkman, IRB Administrator Ann Johnson, IRB Administrator.
What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
Capturing and Reporting Adverse Events in Clinical Research
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Fulfilling the Promise of Medicine Together New FDA Safety Reporting Requirements 2010 John McLane, Ph.D. COO & Vice President Clinical and Regulatory.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Renewing An Approved Protocol: IRB Review Process
Special Topics in IND Regulation
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
Overview of Good Clinical Practices (GCPs)
Defining Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
New Adverse Event Reporting Policy Effective September 1, 2007.
Reporting Adverse Events and Unanticipated Problems to the UAB IRB Policy and Procedure Change September 22, 2006 Amanda G. Murphy, RN, CIP Assistant Director,
Sara Brand Associate Director Research Compliance Administration.
EMORY INSTITUTIONAL REVIEW BOARD VERSION Unanticipated Problems, Protocol Deviations and Non-Compliance.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
IRB Board Education Session 6 How Consent Regulations are Implemented in INSPIR Mary Banks Director, Office of the IRB June -July 2005.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
Planning for Data and Safety Monitoring: Developing Your Study-specific DSMP OCR/GCRC Clinical Research Seminar November 15 th, 2006 Mary-Tara Roth, RN,
IRB BASICS: Issues in Ethics and Human Subject Protections Prepared by Ed Merrill Department of Psychology November 12, 2009.
Understanding Unanticipated Problems (UPs) Elizabeth Ness, RN, MS Director, Staff Development Office of the Clinical Director Center for Cancer Research,
Summary of Findings Improving the System of Reporting and Interpreting Unexpected Serious Adverse Events to Investigators Conducting Research Under an.
Welcome New IRB Members! Today we will discuss: Your Role in the IRB: What to Know The IRB Review Process Resources Human Research Protections.
Copyright FDA Inspections: Where Do Things Go Wrong? Diana Naser RN, MS, CCRP Executive Director Clinical Research Administration Clinical Research.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Criteria For Approval 45 CFR CFR Minimized risks Reasonable risk/benefit ratio Equitable subject selection Informed consent process Informed.
Investigational Devices and Humanitarian Use Devices June 2007.
Conducting Research at Lincoln IRB/HRPP Policies, Procedures & Good Clinical Practices B Kanna MD, MPH, FACP Associate Program Director of Internal Medicine.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
EXCEPTION FROM INFORMED CONSENT IN CPR DEVICE TRIALS: PROTECTION OF PATIENTS’ RIGHTS Circulatory System Devices Panel Meeting September 21, 2004 Elisa.
GEORGIA STATE UNIVERSITY IRB ADAPTED FROM DHHS GUIDANCE ON UNANTICIPATED PROBLEMS Unanticipated Problems.
Main Line Hospitals Institutional Review Board Unanticipated Problems Anne Marie Hobson, BSN, JD, ORA Director Theresa Greaves, ORA Manager.
Bussara Sukpanichnant, Human Subject Protection Office, USAMD-AFRIMS Unanticipated Problems 15 th FERCAP International Conference 24 Nov 15 Nagasaki, Japan.
Good Clinical Practice (GCP) and Monitoring Practices
Instructions for New IRB Continuing Review (Progress) Report
Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.
Reportable Events Emory IRB 9/11/2014.
IRB reporting updates.
FDA’s IDE Decisions and Communications
What is a Data and Safety Monitoring Plan and how do I get one?
Reportable Events & Other IRB Updates February 2017
Adverse Event Reporting: Trials and Tribulations
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Navigating Non-Compliance
SERIOUS ADVERSE EVENTS REPORTING
Unanticipated Problems Involving Risks to Subjects or Others (UPIRSO)
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Reporting to the CPHS: Unanticipated Problems & Serious Adverse Events
Event Reporting in Human Subjects Research
Policy on Prompt Reporting
Common Rule
Research with Human Subjects
Presentation transcript:

Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007

Why Change? OHRP guidance OHRP guidance FDA draft guidance FDA draft guidance Investigators overwhelmed by the reporting requirements Investigators overwhelmed by the reporting requirements IRB swamped by thousands of SAE reports IRB swamped by thousands of SAE reports All things must change to something new, to something strange. Henry Wadsworth Longfellow US poet ( ) Henry Wadsworth Longfellow Henry Wadsworth Longfellow

What the Regulations Say They do NOT talk about AE reporting or SAE reporting They do NOT talk about AE reporting or SAE reporting They talk about the reporting of Unanticipated Problems They talk about the reporting of Unanticipated Problems Both sets of regulations (OHRP &FDA) state that investigators must report to the IRB “any unanticipated problem involving risks to subjects or others” Both sets of regulations (OHRP &FDA) state that investigators must report to the IRB “any unanticipated problem involving risks to subjects or others”

What is an Unanticipated Problem UP =an incident, experience or outcome that meets all three criteria: Unexpected (nature, severity or frequency) Unexpected (nature, severity or frequency) Related or possibly related to participation in the research Related or possibly related to participation in the research Suggests that the research places subjects or others at greater risk of harm than was previously known or recognized OR is Serious * Suggests that the research places subjects or others at greater risk of harm than was previously known or recognized OR is Serious * * see definition of SERIOUS * see definition of SERIOUS

UPs to IRBs UPs by definition are events that are unanticipated, related to the research and serious or a new risk UPs by definition are events that are unanticipated, related to the research and serious or a new risk IRBs must review these promptly, to see if, in light of the new risk, IRBs must review these promptly, to see if, in light of the new risk, the risk benefit ratio is still favorable the risk benefit ratio is still favorable the protocol needs to be modified (additional tests, protections, changes to eligibility) the protocol needs to be modified (additional tests, protections, changes to eligibility) The consent needs to be modified The consent needs to be modified *If the UP is “internal” then the IRB must report the new risk to the “feds”

Adverse Events that are NOT Unanticipated Problems AEs and SAEs which do NOT meet the definition of UPs The IRB must review all available information as part of continuing review The IRB must review all available information as part of continuing review At CR the IRB must determine that all foreseeable risks have been identified and that the study still has a favorable risk benefit ratio At CR the IRB must determine that all foreseeable risks have been identified and that the study still has a favorable risk benefit ratio

Individual AE/SAE Reports Some studies have hundreds of these reports Some studies have hundreds of these reports Impossible to review Impossible to review External SAE reports come with limited information External SAE reports come with limited information As individual reports they do not provide the additional information about the study progress that the board needs to approve the study for continuation As individual reports they do not provide the additional information about the study progress that the board needs to approve the study for continuation

Time for a Change New institutional policies for UP and AE reporting New institutional policies for UP and AE reporting New processes for reporting New processes for reporting Revised forms (soon) Revised forms (soon) New guidance materials and instructions posted on the IRB website New guidance materials and instructions posted on the IRB website

New Process- UPs Unanticipated problems Reported to the IRB using the UPSER form (old SAE form) Reported to the IRB using the UPSER form (old SAE form) Reported within 2 business days of the investigator learning of the incident Reported within 2 business days of the investigator learning of the incident Must come with an explanation as to why this is an UP Must come with an explanation as to why this is an UP Must include how protocol and consent will be modified Must include how protocol and consent will be modified

New Process – AEs and SAEs AEs and SAEs that are not UPs Reported to the IRB at time of PR in summary form Reported to the IRB at time of PR in summary form Reported using UPSER form (or in section PR4 of PR) Reported using UPSER form (or in section PR4 of PR) Do NOT attach the report in Section S of the protocol Do NOT attach the report in Section S of the protocol Must include an evaluation by the PI/AE monitor as to whether Must include an evaluation by the PI/AE monitor as to whether the events, in total, suggest that the research places subjects or others at a greater risk of harm the events, in total, suggest that the research places subjects or others at a greater risk of harm whether new risks have been identified based on AEs whether new risks have been identified based on AEs whether the protocol or consent need to be modified whether the protocol or consent need to be modified

New Process- DSMB Reports DSMB, DMC, AE monitors’ reports Submit them when they are received (don’t hold them until the time of the PR) Submit them when they are received (don’t hold them until the time of the PR) The most recent report must be submitted by the time of the PR so the IRB can use it in their review The most recent report must be submitted by the time of the PR so the IRB can use it in their review Submit using the UPSER form Submit using the UPSER form Do NOT attach in Section S Do NOT attach in Section S Lack of the DSMB report may result in a delay in reviewing the Progress Report Lack of the DSMB report may result in a delay in reviewing the Progress Report

Change in Policy If the study has a formal DSMB then the IRB will accept the DSMB report in place of an AE summary If the study has a formal DSMB then the IRB will accept the DSMB report in place of an AE summary The sponsor may still require you to submit the AE summary to the IRB – the IRB will acknowledge The sponsor may still require you to submit the AE summary to the IRB – the IRB will acknowledge For studies with other data safety monitoring (not DSMB) –the IRB may or may not allow the monitors’ reports to replace the AE summary (IRB may want to see both) For studies with other data safety monitoring (not DSMB) –the IRB may or may not allow the monitors’ reports to replace the AE summary (IRB may want to see both)

Anticipating Problems What if the sponsor wants you to keep submitting individual SAE reports? “To Whom it May Concern” letter posted on the IRB website for the sponsors “To Whom it May Concern” letter posted on the IRB website for the sponsors The IRB cannot continue to accept these reports- there is no regulatory requirement The IRB cannot continue to accept these reports- there is no regulatory requirement

Unanticipated Problems that are NOT Adverse Events By definition an AE is a medical occurrence By definition an AE is a medical occurrence An UP that meets all 3 criteria but is not a medical event An UP that meets all 3 criteria but is not a medical event Charlie leaves the laptop with subject information on the MBTA Charlie leaves the laptop with subject information on the MBTA This would be reported as an UP using the UPSER This would be reported as an UP using the UPSER

“Other Reporting” In most instances AEs, SAEs and unanticipated problems will have to be reported to “others” besides the IRB In most instances AEs, SAEs and unanticipated problems will have to be reported to “others” besides the IRB The change in IRB reporting requirements does not change these requirements The change in IRB reporting requirements does not change these requirements Most sponsors are still going to want you to report to them all AEs and SAEs per their policy Most sponsors are still going to want you to report to them all AEs and SAEs per their policy

FDA Reporting Usually done by the sponsor (investigator reports to sponsor who reports to the FDA) Usually done by the sponsor (investigator reports to sponsor who reports to the FDA) Sponsor Investigators Sponsor Investigators Hold IND (Investigational New Drug ) Hold IND (Investigational New Drug ) Hold IDE (Investigational Device Exemption) Hold IDE (Investigational Device Exemption) Special reporting requirements for reporting of AEs / SAEs/ Unanticipated Problems to the FDA Special reporting requirements for reporting of AEs / SAEs/ Unanticipated Problems to the FDA Sponsor Investigators are required to know and comply with these additional reporting responsibilities Sponsor Investigators are required to know and comply with these additional reporting responsibilities

Data Safety Monitoring Plans In the IRB protocol (Section H) In the IRB protocol (Section H) Data Safety Monitoring Plan (DSMP) Data Safety Monitoring Plan (DSMP) how monitoring will be done how monitoring will be done by whom (who reviews AEs) by whom (who reviews AEs) how frequently how frequently stopping rules stopping rules “the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects” (45 CFR ) “the research plan makes adequate provision for monitoring the data collected to ensure the safety of subjects” (45 CFR ) * November 2007 CR Times will discuss these data safety monitoring groups in more detail

“Serious as a Heart Attack” The IRB (and the feds) take this DSMP seriously The IRB (and the feds) take this DSMP seriously If you say that you will be doing XXX to monitor subject safety- you must do it If you say that you will be doing XXX to monitor subject safety- you must do it (i.e. If the DSMP states that the DSMB or AE monitoring committee will meet 4 times per year then this must occur and the IRB needs documentation) (i.e. If the DSMP states that the DSMB or AE monitoring committee will meet 4 times per year then this must occur and the IRB needs documentation) Failure to follow the DSMP is reportable serious non- compliance Failure to follow the DSMP is reportable serious non- compliance “Plan the work and work the plan”

Resources CR Times Articles CR Times Articles November 2006 “Planning for Data and Safety Monitoring in Clinical Research Studies: Developing Your Study-Specific DSMP” November 2006 “Planning for Data and Safety Monitoring in Clinical Research Studies: Developing Your Study-Specific DSMP” October 2007 “Reporting Unanticipated Problems to the IRB (Formerly SAE Reporting) October 2007 “Reporting Unanticipated Problems to the IRB (Formerly SAE Reporting) November 2007 “Beyond the IRB-Other Adverse Event Reporting Requirements” November 2007 “Beyond the IRB-Other Adverse Event Reporting Requirements” IRB Website IRB Website The Federal Regulations and Guidances The Federal Regulations and Guidances www. www.

Questions? * These slides will be posted on the IRB website under Unanticipated Problem and AE Reporting Thank You !